SE7900737L - Medel - Google Patents

Medel

Info

Publication number
SE7900737L
SE7900737L SE7900737A SE7900737A SE7900737L SE 7900737 L SE7900737 L SE 7900737L SE 7900737 A SE7900737 A SE 7900737A SE 7900737 A SE7900737 A SE 7900737A SE 7900737 L SE7900737 L SE 7900737L
Authority
SE
Sweden
Prior art keywords
water
prostaglandin
average
intravaginal
swelling
Prior art date
Application number
SE7900737A
Other languages
Unknown language ( )
English (en)
Other versions
SE431821B (sv
Inventor
O Johansson
U I Ulmsten
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE7900737A priority Critical patent/SE431821B/sv
Priority to SE7910354A priority patent/SE442167B/sv
Priority to GB8001176A priority patent/GB2041220B/en
Priority to DE19803001454 priority patent/DE3001454A1/de
Priority to US06/112,563 priority patent/US4352790A/en
Priority to JP519880A priority patent/JPS55102512A/ja
Priority to NL8000426A priority patent/NL190693C/xx
Priority to NO800186A priority patent/NO153520C/no
Priority to BE0/199113A priority patent/BE881351A/fr
Priority to FR8001797A priority patent/FR2447191A1/fr
Priority to DK033580A priority patent/DK160739C/da
Publication of SE7900737L publication Critical patent/SE7900737L/sv
Publication of SE431821B publication Critical patent/SE431821B/sv
Priority to DK316186A priority patent/DK160740C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7900737A 1979-01-29 1979-01-29 Lagringsstabilt, prostaglandininnehallande medicinskt preparat SE431821B (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE7900737A SE431821B (sv) 1979-01-29 1979-01-29 Lagringsstabilt, prostaglandininnehallande medicinskt preparat
SE7910354A SE442167B (sv) 1979-01-29 1979-12-17 Lagringsstabilt prostaglandin innehallande medicinskt preparat
GB8001176A GB2041220B (en) 1979-01-29 1980-01-14 Medical preparations containing prostaglandins
DE19803001454 DE3001454A1 (de) 1979-01-29 1980-01-16 Stabiles, prostaglandin-haltiges arzneimittel
US06/112,563 US4352790A (en) 1979-01-29 1980-01-16 Medical preparation containing prostaglandin
JP519880A JPS55102512A (en) 1979-01-29 1980-01-18 Blend and its administration
NL8000426A NL190693C (nl) 1979-01-29 1980-01-23 Stabiel, prostaglandine bevattend, farmaceutisch preparaat.
NO800186A NO153520C (no) 1979-01-29 1980-01-25 Fremgangsm¨te til fremstilling av et stabilt preparat inne holdende prostaglandin.
BE0/199113A BE881351A (fr) 1979-01-29 1980-01-25 Preparation medicale
FR8001797A FR2447191A1 (fr) 1979-01-29 1980-01-28 Preparation medicale contenant de la prostaglandine et son utilisation pour application intravaginale et intracervicale
DK033580A DK160739C (da) 1979-01-29 1980-01-28 Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse
DK316186A DK160740C (da) 1979-01-29 1986-07-03 Stabilt prostaglandin-indeholdende praeparat til anvendelse som abortfremkaldende middel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7900737A SE431821B (sv) 1979-01-29 1979-01-29 Lagringsstabilt, prostaglandininnehallande medicinskt preparat

Publications (2)

Publication Number Publication Date
SE7900737L true SE7900737L (sv) 1980-07-30
SE431821B SE431821B (sv) 1984-03-05

Family

ID=20337129

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7900737A SE431821B (sv) 1979-01-29 1979-01-29 Lagringsstabilt, prostaglandininnehallande medicinskt preparat
SE7910354A SE442167B (sv) 1979-01-29 1979-12-17 Lagringsstabilt prostaglandin innehallande medicinskt preparat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7910354A SE442167B (sv) 1979-01-29 1979-12-17 Lagringsstabilt prostaglandin innehallande medicinskt preparat

Country Status (10)

Country Link
US (1) US4352790A (sv)
JP (1) JPS55102512A (sv)
BE (1) BE881351A (sv)
DE (1) DE3001454A1 (sv)
DK (2) DK160739C (sv)
FR (1) FR2447191A1 (sv)
GB (1) GB2041220B (sv)
NL (1) NL190693C (sv)
NO (1) NO153520C (sv)
SE (2) SE431821B (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0323530B2 (sv) * 1979-03-21 1991-03-29 Nat Res Dev
US5079009A (en) * 1979-03-21 1992-01-07 National Research Development Corporation Controlled release compositions including polyethylene oxide with urethane cross-linking
IT1131833B (it) * 1980-06-20 1986-06-25 Crinos Industria Farmaco Eccipienti per sostanze spermicide
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
DE3307816A1 (de) * 1983-03-02 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
DE3428264A1 (de) * 1984-07-27 1986-03-06 Schering Ag Gelhaltige pharmazeutische zubereitungen
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
CH678697A5 (sv) * 1989-04-03 1991-10-31 Warner Lambert Co
WO1993008804A1 (en) * 1991-11-08 1993-05-13 Kyoto Pharmaceutical Industries, Ltd. Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
US6946442B2 (en) * 1994-11-30 2005-09-20 Asif Syed Ahmed Method of hastening cervical ripening
ATE226826T1 (de) * 1995-06-01 2002-11-15 Searle & Co Misoprostolhaltige feste stabilisierte dispersionen
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
FR2766709B1 (fr) 1997-07-31 2000-04-07 Dominique Cingotti Procede pour la preparation d'un extrait de principes actifs sous forme de microgranules a base de fibres alimentaires entierement solubles destines a differentes formes galeniques
US6031002A (en) * 1998-05-01 2000-02-29 Michael Ebert Method for enhancing female sexual response and a composition therefor
US5891915A (en) * 1998-05-01 1999-04-06 Wysor; Michael S. Method for enhancing female sexual response and an ointment therefor
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
US3888975A (en) * 1972-12-27 1975-06-10 Alza Corp Erodible intrauterine device
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AR205997A1 (es) 1973-11-21 1976-06-23 American Cyanamid Co Resina de poliester normalmente solida biodegradable e hidrolizable
CH616694A5 (en) * 1974-06-27 1980-04-15 Ciba Geigy Ag Process for the preparation of crosslinked, water-insoluble, hydrophilic copolymers
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
JPS5256148A (en) * 1975-10-16 1977-05-09 Agency Of Ind Science & Technol Process for preparing active substances having improved
GB1554783A (en) 1976-01-05 1979-10-31 Population Res Inc Pharmaceutical compositions for use in the permanent sterilization of female animals
DE2709804C2 (de) * 1976-03-12 1986-03-13 Ono Pharmaceutical Co. Ltd., Osaka Prostaglandin-analoga, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
GB1551620A (en) * 1976-12-13 1979-08-30 Ici Ltd Delivery means for biologically active agents

Also Published As

Publication number Publication date
DE3001454A1 (de) 1980-08-07
JPS55102512A (en) 1980-08-05
DK160739C (da) 1991-09-30
BE881351A (fr) 1980-05-16
GB2041220A (en) 1980-09-10
SE442167B (sv) 1985-12-09
FR2447191A1 (fr) 1980-08-22
DK160740C (da) 1991-09-30
DK33580A (da) 1980-07-30
NL190693B (nl) 1994-02-01
US4352790A (en) 1982-10-05
DK160739B (da) 1991-04-15
DK316186A (da) 1986-07-03
SE7910354L (sv) 1980-07-30
DK160740B (da) 1991-04-15
JPH0140013B2 (sv) 1989-08-24
NO800186L (no) 1980-07-30
NL190693C (nl) 1994-07-01
NO153520C (no) 1986-04-09
DK316186D0 (da) 1986-07-03
SE431821B (sv) 1984-03-05
DE3001454C2 (sv) 1990-05-10
FR2447191B1 (sv) 1983-07-22
NL8000426A (nl) 1980-07-31
NO153520B (no) 1985-12-30
GB2041220B (en) 1983-07-27

Similar Documents

Publication Publication Date Title
SE7900737L (sv) Medel
NO172726C (no) Absorberende forbindingsmateriale eller hygieneprodukt i vannuopploeselig form
ATE8459T1 (de) Pharmazeutische zubereitung in form eines polyacrylatfilmes und deren herstellung.
SE8501370D0 (sv) Lagerstabila snabbsonderfallande farmaceutiska presstycken av verksamt material
CA2095728A1 (en) A gel-forming liquid carrier composition
AU553340B2 (en) Fast drying semi-rigid zinc oxide bandage
ES2035847T3 (es) Un procedimiento para la elaboracion de una preparacion farmaceutica.
ATE14527T1 (de) Auftragsvorrichtung fuer pharmazeutische wirkstoffe, ihre herstellung und gebrauch.
SE7709112L (sv) Berarfixerade enzym och framstellning derav
SE8404182L (sv) Indometacin innehallande, gelartad salva
ES2019589T5 (es) Procedimiento para la fabricacion de una envuelta hinchable para cables.
IT1065634B (it) Polimero idrofilico e procedimento per la preparazione dello stesso
SE8103833L (sv) Spermiedodande komposition
SE7904307L (sv) Forfarande for framstellning av vattenolosliga absorptionsmedel
DE3264331D1 (en) Aqueous preparation and its use in the preparation of ceramic masses
NO861750L (no) Anvendelse av et vandig system inneholdende svellende makromolekyler som slukkevann.
US4539200A (en) Treatment of skin lesions
DE3782652D1 (de) Zubereitung zum stoppen von angiogenese und einem kapillar-, zellen- oder membranleck.
ES2113872T3 (es) Composiciones de tampones y procedimiento para su preparacion.
MX160834A (es) Procedimiento para la preparacion de soluciones acuosas concentradas y estables en almacenamiento de aclaradores de bencimidazolio
GB748135A (en) Improvements in and relating to tampons, pads and the like
JPS565137A (en) Water absorbing agent with excellent stability against salt
ES469822A1 (es) Un procedimiento para la preparacion de composiciones de prostaglandina con mayor estabilidad.
IT7947822A0 (it) Composizione per prevenire o curare la dissenteria dei suini e relativo procedimento di impiego
JPS55149212A (en) Gradually releasing preparation of methotrexate

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7900737

NAL Patent in force

Ref document number: 7900737-3

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490102, 861107, EXPIRES: 20001128

NUG Patent has lapsed

Ref document number: 7900737-3

Format of ref document f/p: F